George Sands/LinkedIn, Pierre Elias/columbia.edu
Mar 8, 2026, 15:41
George Sands: AI Screening Tool for Early Detection of Heart Disease
George Sands, Former Senior Director at Pfizer, shared a post on LinkedIn:
“This is a phenomenal development, led by cardiologist Pierre Elias, at Columbia, where an ortho patient, without know cardio symptoms, was found to have a cardiology condition that was treated within the 7 days of diagnosis by this AI screening tool.
The future is here!
It will help patients and the clinicians who care for them. Bravo and thanks to Dr. Elias’s team.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation